Agenus Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AGEN research report →
Companywww.agenusbio.com
Agenus Inc. , a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies.
- CEO
- Garo H. Armen
- IPO
- 2000
- Employees
- 316
- HQ
- Lexington, MA, US
Price Chart
Valuation
- Market Cap
- $131.17M
- P/E
- 1.85
- P/S
- 1.06
- P/B
- -0.54
- EV/EBITDA
- 4.54
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 52.14%
- Op Margin
- 6.62%
- Net Margin
- 52.16%
- ROE
- -23.05%
- ROIC
- 10.53%
Growth & Income
- Revenue
- $114.20M · 10.37%
- Net Income
- $115.00K · 100.05%
- EPS
- $-0.00 · 99.97%
- Op Income
- $-20,556,000
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $7.34
- 52W Low
- $2.71
- 50D MA
- $3.77
- 200D MA
- $3.87
- Beta
- 1.61
- Avg Volume
- 928.65K
Get TickerSpark's AI analysis on AGEN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 15, 26 | ARMEN GARO H | other | 4,540 |
| May 1, 26 | ARMEN GARO H | other | 4,233 |
| Apr 24, 26 | Hirsch Susan B | other | 105,000 |
| Apr 24, 26 | Buell Jennifer | other | 300,000 |
| Apr 24, 26 | Buell Jennifer | other | 5,000 |
| Apr 24, 26 | O'Day Steven J | other | 95,333 |
| Apr 24, 26 | O'Day Steven J | other | 70,000 |
| Apr 24, 26 | HARRISON THOMAS L | other | 122,500 |
| Apr 24, 26 | Wright Timothy | other | 105,000 |
| Apr 24, 26 | Charette Austin | other | 17,619 |
Our AGEN Coverage
We haven't published any research on AGEN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AGEN Report →